1. Antozzi, Carlo, Emilia Berta, and Paolo Confaloneri. Protein-A immunoadsorption in immunosuppression-resistant myasthenia gravis. Lancet (North American ed.) vol. 343, p124. Jan 8, 1994.

  2. Araga, Shigeru, Robert D. LeBoeuf, and Edwin Blalock, Jr. Prevention of Experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor. Proceedings of the National Academy of Sciences of the United States, vol. 90, no. 18, p 8747 (5). Sept 1993.

  3. Autoimmunity and Neurologic Disorders, Medical Sciences Bulletin, Pharmaceutical Information Associates. Sept 1994.

  4. Campbell, Neil. Biology, third edition. NY: The Benjamin/Cummings Publishing Company, Inc., 1993.

  5. Curtis, H., Barnes,N. Biology, fifth edition. NY: WOrth Publishers, Inc., 1989.

  6. DeBaets, Marc H., and Hans J. G. H. Oosterhuis, eds. Myasthenia Gravis. Boca Raton: CRC Press, 1993.

  7. Dobkin, Bruce H. Standing Tall Discover, vol. 15 no. 9, p58. Sept 1994.

  8. Drachman, Daniel B., Myasthenia Gravis, New England Journal of Medicine, vol. 330 no. 25, pp. 1797-1810. 1994.

  9. Drachman, D. B. (1994). Medical Progress: Myasthenia Gravis. The New England Journal of Medicine, 330, (25), 1797-1810.

  10. Goodman and Gilman. The Pharmacological Basis of Therapeutics, seventh edition. NY, NY: MacMillan Publishing Co. 1985.

  11. Hutchinson, D.O., A. G. Engel, T.J. Walls, S. Nakano, S. Camp, P. Taylor, C. M. Harper, and J. M. Brengman. The Spectrum of Congenital End-plate Acetylcholinesterase Deficiency. Annals New York Academy of Sciences. pp. 469-485. 1993.

  12. Jorgenson, E., E. Hartwieg, K. Schuske, M.L. Nonet, Y. Sin and H.R. Horvitz, Defective recycling of synaptic vesicles in synaptotagmin mutants of C. elegans in preparation, 1995.

  13. Katz-Levy, Yael, Susan L. Kirshner, Michael Sela, and Edna Mozes, Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs, Proceedings of the National Academy of Sciences of the United States, vol. 90, no. 15, p7000 (5). Aug 1993

  14. Kandel, Eric R., James H. Schwartz, and Thomas M. Jessell (eds.). Principles of Neural Science, third edition. NY, NY: Elsevier Science Publishing Co. 1991.

  15. Lemon,Chris. IVIG Use in Myasthenia Gravis.
    Retrieved from: http://pharmacy.isu.edu/idis/news/news0001.html

  16. Lisak, Robert P., ed. Handbook of Myasthenia Gravis and Myasthenic Syndromes. New York: Marcel Dekker, 1994.

  17. McIntosh, Kevin R., and Daniel B. Drachman. Induction of Suppressor Cells Specific for AChR in Experimental Autoimmune Myasthenia Gravis. Science, vol. 232, p 401. April 1986.

  18. Modelling the Acetylcholine Receptor Channel.
    Retrieved from: http://sunny.mpimf-heidelberg.mpg.de/people/vkitzing/AChR.html

  19. Moreau, Thibault, Stephane Vandenabeele, Patricia Depierre. Nicotine-sensitive Myasthenia Gravis. Lancet (North American ed.) vol. 345, pp 61-62. Jan. 7, 1995.

  20. Myasthenia Gravis Fact Sheet.

  21. Myasthenia Gravis. A Case Study.

  22. Neuromuscular Disease (AAN Continuum): Myasthenia Gravis
    Retrieved from: http: //synapse.uah.ualberta.ca/aan/00040000.htm

  23. Pestronk, A., D.B. Drachman M.D., S.G. Self, Measurement of Junctional AcHR in myasthenia gravis: clinical correlations, Muscle Nerve, 8:241-512. 1985.

  24. A practical guide to the recognition and management of myasthenia gravis.

  25. Protein Pieces Halt Autoimmune Response. Science News, vol 144, p109. Aug 14, 1993.

  26. Putman, Maryann T. and Robert A. Wise. Myasthenia gravis and upper airway obstruction. Chest, vol. 109, no. 2, p 400. February 1996.

  27. Saib, Ali, Martine Canivet, and Marie-Louise Giron. Human foamy virus infection in myasthenia gravis. Lancet (North American ed.), vol. 343, p666. Mar 12, 1994.

  28. Serie, Janet R. Biology 21: Cellular and Molecular Biology Text and Problem Book. 1995/96 ed.

  29. Shepherd, Gordon. Neurobiology, third edition. NY: Oxford University Press, 1994.

  30. Tsung, Kemin and Jorman S. Seggev. An unusual case of dysphagia, The Western Journal of Medicine, vol. 163, no. 2, p 159. August 1995.

  31. Zweiman, Burton, and Arnold I. Levinson. Immunologic Aspects of Neurological and Neuromuscular Diseases, The Journal of the American Medical Association, vol. 268, no. 20, pp 2918 (5). Nov 25, 1992.

Return to Home Page